Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FlowGenix is a medical technology company specializing in the development of non-invasive hemodynamic monitoring solutions for patients with chronic heart failure. The company's primary innovation is a wearable sensor designed to monitor pulmonary artery pressure and other key cardiovascular metrics in real-time, providing a patient-friendly alternative to invasive implantable monitors. By enabling continuous data collection outside of clinical settings, FlowGenix aims to facilitate early intervention and significantly reduce hospital readmission rates for heart failure patients. The company originated as a spin-off from the University of Miami and is focused on bridging the gap between clinical-grade diagnostics and wearable convenience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flow Genix.